Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454999 · ClinicalTrials.gov registry record · Phase 1
Cell Phone-Based Expert Systems for Smoking Cessation
A Phase 1 study, sponsored by VA Pacific Islands Health Care System.
- Completed
- Registry status
- Phase 1
- Development phase
- 446
- Enrollment target
NCT01454999: Completed Phase 1 study, sponsored by VA Pacific Islands Health Care System.
NCT01454999 is a Phase 1 study that has completed, run by VA Pacific Islands Health Care System. The registered enrollment target is 446 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (643% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01454999, a Phase 1 study, has completed, sponsored by VA Pacific Islands Health Care System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 446 participants
- Enrollment target
Study Summary
This project aims to enhance the emotional and physical well-being of veterans through the reduction of smoking by utilizing a web-based, computerized tailored intervention (CTI) with feedback messages delivered via cell phone. CTIs have shown increasing promise as useful behavior change programs for improved health behaviors. A variety of modalities are to deliver personalized CTI information and feedback; however, the ubiquity and sophistication of today's wireless mobile technologies represent new modes of delivery for empirically based smoking cessation and other behavioral health interventions. The CTI is based on the empirically-supported Transtheoretical Model of Behavior Change (TTM). A web-based CTI modified for a veteran population will be used to pilot test the effectiveness of the CTI alone and CTI plus individualized text messaging enhancements. The pilot study is a randomized controlled trial to assess the cell phone's feasibility as an intervention modality for changing smoking behaviors. This will be the first study to adapt a smoking cessation Internet-based CTI to provide personalized feedback on a cell phone to reduce smoking behaviors in military veterans.
Primary Outcome
7-day point prevalence (self-report)
Interventions
- BEHAVIORAL CTI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-03 |
| Phase | Phase 1 |
What the finished NCT01454999 record still lists
NCT01454999 is an interventional study that assigns participants to a tested intervention. The registered 446 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (643% higher).
The record links to 0 conditions, and to 1 intervention - of which CTI is the first listed.
NCT01454999 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01454999 about?
NCT01454999 is a clinical study titled "Cell Phone-Based Expert Systems for Smoking Cessation". This project aims to enhance the emotional and physical well-being of veterans through the reduction of smoking by utilizing a web-based, computerized tailored intervention (CTI) with feedback messages delivered via cell phone. CTIs have shown increasing promise as useful behavior change programs fo...
What is the current status of trial NCT01454999?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 446 participants. The study started on 2009-09. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01454999?
The interventions under investigation include: CTI (BEHAVIORAL).
Who is sponsoring clinical trial NCT01454999?
This trial is sponsored by VA Pacific Islands Health Care System, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01454999's enrollment target sits among peer trials
446 59th of 2000 higher than 1,942 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia